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Background: To determine whether an integrated approach to coordination of care influences hospitalization and
clinical outcomes in a chronic neurological disease, amyotrophic lateral sclerosis.
Methods: We followed up 2452 patients with probable or definite amyotrophic lateral sclerosis from 2000 to 2012.
Two cohorts were compared before and after the creation of a community care network for this disease in Ile de
France in 2006. During these two periods, the medical and paramedical care teams and formal standards of care
were identical; the only difference was the coordination by the network. To investigate hospital and emergency
department use, we used number of patients, number of stays, and number of days. For clinical outcomes, we used
slopes of functional deterioration, and Kaplan–Meier and Cox models for survival.
Results: All hospitalization variables decreased after the creation of the network, which was not explained by admissions
elsewhere. The slope of functional deterioration was significantly different before (1.03 ± 1.57 points/month) and after
(0.79 ± 0.80 points/month; p = 0.002) creation of the network. Patients included in the network had a median survival
time of 13.2 months more (log rank test; p < 0.001). In the Cox model, the network intervention was associated with a
45% decrease in relative risk of death during the period of the study (p < 0.001).
Conclusions: Network care was associated with fewer hospital admissions, reduced functional deterioration and later
mortality in ALS. These results suggest that proactive coordination between carers in chronic and complex diseases could
have a positive impact on hospitalization and the clinical course of the disease.
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An important challenge for health systems is patients
with complex diseases requiring care from multiple
healthcare professionals over time. This has given rise to
the concept of multidisciplinary care in chronic diseases,
including neurological diseases [1-3].
Multidisciplinary care is only one aspect of team
healthcare [4] and has no single pattern of operation [5].
However, continuity of information is especially import-
ant in improving team performance [6,7]. Team coordin-
ation can reduce the negative consequences of silo
decision-making, where different carers independently* Correspondence: vincent.meininger@psl.aphp.fr
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pact on continuity of care, particularly when the patient
returns home.
To improve team healthcare, we set up a 2-year uni-
versity course to train care pathway coordinators in co-
ordinating other healthcare professionals (Additional file
1). To evaluate the impact of these new professionals,
we focused on one chronic neurological disease affecting
all aspects of health, amyotrophic lateral sclerosis (ALS).
Since 2000 (see details in Additional file 1), nearly all
ALS patients in the Ile de France region (IDF) have been
followed up by the same single team following the same
multidisciplinary care protocol. This team was based at a
dedicated specialized center at Salpêtrière Hospital,
Paris. Since 2005, a team of care pathway coordinatorsal. This is an Open Access article distributed under the terms of the Creative
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side the Salpêtrière team.
To analyze their impact, we compared outcomes in
two groups of ALS patients: those seen before October
2005 (patients before network: PBN group) and those
seen after that (patients in network: PIN group).Methods
Data sources and study population
For hospital admissions at Salpêtrière Hospital, the data
used came from the Programme Médicalisé des Systèmes
d’Information (PMSI), which systematically records all
data during each hospital admission.
For clinical impact of coordination, we used the med-
ical data from our database and we compared the data
of the PIN group since 1st October 2005 with data of
the PBN group followed up between 1st January 2000
and 1st October 2005. Patients from the PBN group
who entered the network were excluded from the study
irrespective of their date of entry, which did not affect
the analyses (Additional file 2). We took into account
only “incident” patients, i.e., patients whose diagnosis
was definitely established at their time of enrollment in
the center (PBN) or in the network (PIN). This study
was approved by the Ethical Committee of Salpêtrière
Hospital, which agreed that consent was not necessary
under French law. A similar proportion of patients in
each group (8.9% in the PBN, 8.3% in the PIN) partici-
pated in clinical trials during their follow up. All patients
had a diagnosis of possible, probable or definite ALS ac-
cording to the El Escorial criteria [8]. For the survival
analysis, date of death was confirmed by the treating
physician, the family and, if necessary, the death certifi-
cate from the town hall.
To evaluate the number of ALS patients in IDF, we
used the SNIRAM (Système National Inter Régime d’As-
surance Maladie) database, available since 2012, which
collects all medical information for patients. In France,
all ALS patients are given riluzole (Rilutek®), so monitor-
ing riluzole consumption gives almost complete data on
the number of patients with ALS.Clinical measures and functional outcomes
The following data were collected: age, sex, site and date
of onset, delay since onset of the disease [9], date of
death, date of gastrostomy, date of non-invasive ventila-
tion and riluzole consumption.
The progression rate of function at first visit (ΔFS)
[10] was calculated. Since the ALSFRS-R decline is linear
[11], we used the PIN group to compare the slope of the
ALSFRS-R scale before the introduction of coordinated
care with the slope during follow-up by the care pathway
coordinator.Hospitalization data
For admissions to Salpêtrière Hospital, we analyzed the
number of patients hospitalized for more than 24 hours,
the number of stays (each stay was counted, even if a pa-
tient came back several times) and the number of days
in hospital.
Statistical analysis
Quantitative variables were compared by analysis of
variance (ANOVA) and qualitative variables using Pear-
son’s chi-squared test. Quantitative variables were di-
chotomized. The cut-offs used were 60 years for age and
1.09/month for the slope at entry of the ALSFRS-R.
For the survival analyses in the PIN group, we retained
patients included between 1st October 2005 and 31st
December 2008 to avoid biasing the survival data by pa-
tients with insufficient follow-up. For the surviving pa-
tients, date of censoring was 1st October 2013 for the
PIN group and 1st January 2008 for the PBN group to
avoid an imbalance in the observed follow-up period be-
tween the two groups (i.e., a maximum of 8 years for
both groups).
The survival curves for the PIN and PBN groups were
compared using the Mantel Cox log-rank test. Prognostic
factors for survival were assessed using the Cox propor-
tional hazard method, by entering into the model dichot-
omous variables: participation in the network, age at
disease onset, site of disease onset, gender, ΔFS, NIV
(non-invasive ventilation) and gastrostomy. The possible
role of cognitive impairment as a prognostic factor was
not used considering the lack of certainty on its role [12].
All significance levels were two-sided with a probabil-
ity threshold of p < 0.05. All statistical analyses were car-
ried out with SPSS version 11 · 0.
Results
Effect of coordinated care on hospital admissions
From 2000 to 2012, 2452 patients were followed up, with
188 (±16) patients enrolled per year. The mean enroll-
ment rate was similar between the two groups (Table 1).
In 2012, 623 patients were given riluzole in the IDF
(SNIRAM database) and the network monitored 570 pa-
tients, i.e., 91.5% of patients with ALS in the IDF. Table 1
shows all variables for hospitalization decreasing over
time after the initiation of the coordinated care. The
proportion of patients admitted to Salpêtrière compared
with other hospitals remained stable at around 91%,
confirming that there was no reallocation of patients to
other hospitals in Ile de France.
Effect of coordinated care on interventions
We assessed the impact of the coordinated care on the
main therapeutic interventions in ALS [13]. All patients
were treated with riluzole. For gastrostomy, both the
Table 1 Data for hospitalization, incidence and prevalence
Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Total number of patients
followed up
413 418 413 457 418 414 433 457 514 543 559 572 570
Absolute number of patients
admitted
328 354 367 422 358 222 181 202 193 198 216 192 216
Proportion of patients
admitted (1)
79,42% 84,69% 88,86% 92,34% 85,65% 53,62% 41,80% 44,20% 37,55% 36,46% 38,64% 33,57% 37,89%
Annual number of stays (2) 469 498 566 581 546 290 209 232 220 236 261 231 266
Rehospitalization frequency
index (3)
1,43 1,41 1,43 1,38 1,53 1,31 1,15 1,15 1,14 1,19 1,21 1,20 1,23
Risk of admission per patient
index (4)
1,11 1,19 1,37 1,27 1,28 0,70 0,51 0,62 0,38 0,31 0,35 0,32 0,36
Ratio/emergency (5) 7,33% 7,18% 7,99% 4,60% 6,07% 6,28% 6,62% 6,67% 2,97% 3,75% 3,78% 4,14% 4,28%
1- Ratio of number of patients admitted during 1 year/number of patients followed up in the same year by the network.
2- Total number of hospitalizations or stays, each stay was counted, even if a patient came back several times.
3 -Ratio of hospital stays to the number of patients admitted to hospital.
4- Ratio of hospital stays to the total number of patients followed up.
5- Ratio of patients admitted for uncontrolled emergency situations to the total number of patients followed up.
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val between disease onset and gastrostomy (PIN 32.0 ±
27.1 months vs PBN 28.5 ± 15.2 months; p = 0.22) were
not modified by the introduction of the coordinated
care. Since 2002, 584 patients received NIV, with a regu-
lar increase in the proportion of ventilated patients/year
from 8.1% in 2002 to 36.3% in 2012. Other formal stan-
dards of care regarding concomitant medications (in-
cluding use of antibiotics) remained strictly identical
from 2000 to 2012. For administrative reasons, use of
cough assistance or high frequency chest wall oscilla-
tions was not allowed until 2013 and was not used by
the patients in our study. In summary, from 2000 to
2012 the medical management of patients was not for-
mally modified, except for NIV.
Effect of coordinated care on survival and rate of
functional deterioration
To study the effect of the coordinated care on functional
deterioration, we used the PIN group to compare the
slope before the inclusion of patients in the coordinated
process and that during their subsequent follow-up (n =
506). There was a significant difference in average slope
before entry to the network and during the follow-up by
the network (1.03 ± 1.57 points/month before the net-
work; 0.79 ± 0.80 points/month during; p = 0.002).Table 2 Demographic characteristics of ALS patients before t
Variable (mean +/− SD) Pat
Age (year) 62
Sex (% male) 52.8
Site of onset (bulbar/spinal) % 33/
Disease duration (month) before enrollment 21.8
ΔFS (/month) at entry mean (SD) 0 · 9To establish the effect of the coordinated care on sur-
vival, two groups of patients (PIN and PBN) were com-
pared. These two groups were balanced for the most
powerful prognostic variables (Table 2). There was a sig-
nificant difference in survival curves for the PIN group
compared with the PBN group (log rank test; p < 0.001;
median survival 38.8 months for the PIN group vs 25.6
months for the PBN group) (Figure 1).
Univariate analysis showed a significant association
with survival for age, gender, site of onset, initial slope of
deterioration, NIV, gastrostomy and coordinated care
(Hazard ratio for care = 0.502 [95% CI: 0.439–0.573; p <
0.001]). In a multivariate analysis (Table 3), the model
retained only site of onset, initial slope of deterioration
and the coordinated care. Age, gender, NIV, and gastros-
tomy were not retained. Sensitivity analyses were con-
ducted to clarify the possible role of long survivors and
NIV (Additional file 2).Discussion
Our study compared two types of care management: a
multidisciplinary approach carried out at the hospital only
and a coordinated care between home and hospital by
trained professionals. Our results show that the coordi-
nated care decreases the number of hospital admissionshe network (PBN) and in the network (PIN)
ients before network Patients in network
· 6 (11 · 7) 61 · 2 (12 · 9)
% 54.8%
67 34 · 4/65 · 6
(19.2) 21.5 (17.8)
7 (0 · 78) 0 · 94 (1 · 60)
Figure 1 Kaplan–Meier plots of survival in ALS patients before
(PBN) and after (PIN) coordinated care introduction.
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delay mortality.
Our results showed a marked decrease in hospital ad-
missions with the initiation of the coordinated care. This
decrease was not due to a reallocation of patients, nor to
longer hospital stays because the mean annual number
of days of hospitalization remained stable at 3.3 days
(Table 1). There are several possible explanations for this
impact on hospital admissions. An interaction with a
change in care trends over time [14] is unlikely since
both the paramedical and medical care teams remained
strictly identical from 2000 to 2012. Due to this stability,
all the standards of care, including concomitant medica-
tions and nutritional recommendations, and protocols
for care both in and out of hospital, and for home
health/hospice care remained strictly identical during
the two periods of comparison. The possible role ofTable 3 Survival analysis adjusted for prognostic factors
(Cox model)
HR 95% CI for HR p
Age 0 · 845 0 · 649–1 · 029 0 · 094
Sex 0 · 915 0 · 748–1 · 118 0 · 384
Site of disease onset 1 · 789 1 · 433–2 · 235 0 · 001
Slope deterioration 0 · 326 0 · 261–0 · 406 0 · 001
NIV 1 · 251 0 · 953–1 · 642 0 · 106
Gastrostomy 0 · 985 0 · 775–1 · 252 0 · 901
Coordinated care (PBN/PIN) 0 · 549 0 · 439–0 · 687 0 · 001
Legend: All variables are dichotomized. The cut-offs used were 60 years for
age and 1 · 09/month for the slope at entry of the ALSFRS-R (ratio 2/3, 1/3). For
disease onset, 0 was bulbar, 1 was spinal.clinical trials was not retained since the proportion of
patients included in these trials was identical in the two
groups.
Given this stability, the better outcomes observed
since 2006 are likely to be a direct consequence of the
care management, as previously suggested [15]. The bet-
ter scheduling of care reduces the need for emergency
admissions. It reduces the multiple concurrent medical
issues, which are major drivers of hospital admission
[16]. The coordination of care allows personalised care
coordination integrating all medical, psychological and
social aspects of management over the entire disease
duration. The coordinators provide a tight link between
community-based carers and the hospital. Furthermore,
their follow-up at home by regular telephone calls help
verify adherence to medical recommendations. This co-
ordination improves adherence to recommendations and
avoids breaks in the continuity of care, and potential
sources of difficulties for patients and carers [7].
Changes over time in the population studied can be
another source of bias. All characteristics of our patients
(Table 2) were stable and comparable to those previously
reported [16]. Given the data of SNIRAM, it appears
that nearly 92% of ALS patients in Ile de France were in-
cluded in the study, making selection bias unlikely.
We observed a relationship between the coordinated
care and health status by slowing down the rate of func-
tional deterioration and by improving survival time. For
both cohorts, we used the same HAS guidelines [13] for
care management. Even if not randomized, our study
compared two groups of patients with otherwise strictly
identical care management. Unidentified prognostic fac-
tors could explain the difference in survival, but the two
groups were comparable for the main ALS prognostic
factors. The possible role of cognitive impairment as a
prognostic factor was not retained because of the lack of
certainty on its role [12].
Only two care variables differed: the coordinated care
and the more frequent use of NIV. Using the Cox model
adjusted for the most significant variables in ALS [17],
the univariate analysis shows that both coordinated care
and NIV influence the survival outcome. In the multi-
variate analysis, coordinated care had a stronger impact,
although this does not mean that it is solely responsible
for the improved outcome. Sensitivity analyses strengthen
this conclusion (Additional file 2). We previously reported
an improvement in survival times since 2005 [18], and we
suggested that NIV might play a role in this. However,
we were not able to provide quantitative data on venti-
lation and we did not take into account the role of the
coordinated care. This study now confirms our previ-
ous conclusions on the improvement of survival times
and the role of NIV but adds new information on the
role of coordination of care.
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tion in ALS has been disputed [19]. A recent study [20]
concluded that case management in addition to multi-
disciplinary care in ALS did not improve health-related
quality of life or modify disease progression. However,
the outcomes were different, there were missing data
and the paper did not provide clear data on the real in-
volvement of the case managers.
Multidisciplinary care has been an important, but in-
complete step in care improvement. Other disappointing
experiences were proposed such as the “patient-centered
medical home” in which a medical practice actively man-
aged patients’ chronic conditions [21]. A possible reason
for such disappointing results, including in ALS [20],
could be the need for primary care practices to have a
strong system of care managers [22]. In our study, rating
the intensity of the management [23] showed that the
coordinators reached 16 criteria out of 18, which favors
high intensity management. Our results indicate that
such an intense system of care management by care
managers intervening between the hospital and the com-
munity and between healthcare professionals, patients
and carers had a favorable effect on both hospital admis-
sions and prognosis in a specific model of chronic dis-
ease. The confirmation of these conclusions by further
studies could have a major impact on national health
system strategies and implementation of new jobs in
health care.
Conclusions
In this study, network care was associated with fewer
hospital admissions, reduced functional deterioration
and later mortality in ALS. These results suggest that
compared to a multidisciplinary care a proactive coord-
ination between carers in chronic and complex diseases
could have a positive impact on hospitalization and the
clinical course of the disease.
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